|
|
Blood, 1 April 2006, Vol. 107, No. 7, pp. 2680-2685.
Prepublished online as a Blood First Edition Paper on December 6, 2005; DOI 10.1182/blood-2005-07-2622.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation
Tom J. Vulliamy,
Anna Marrone,
Stuart W. Knight,
Amanda Walne,
Philip J. Mason, and
Inderjeet Dokal
From the Department of Haematology, Division of Investigative Science, Imperial College London, Hammersmith Hospital, United Kingdom; Pharmaceutical Research Division, King's College, London, United Kingdom; and Department of Internal Medicine, Washington University Medical School, Saint Louis, MO.
The two genes mutated in the bone marrow failure syndrome dyskeratosis congenita (DC) both encode components of the telomerase complex responsible for maintaining the ends of chromosomes in stem cells and in the germ line. In reviewing the mutation profile that is found in DC, we describe 9 novel mutations in the DKC1 gene and 3 novel TERC mutations responsible for the X-linked and autosomal dominant forms of the disease, respectively, but find that two thirds of the families do not have mutations in either of these genes. In a significant subset of these uncharacterized families, the index case presents with severe disease previously defined as the Hoyeraal Hreidarsson (HH) syndrome. The diverse clinical phenotype seen in patients with X-linked DC is not explained by the different amino acid substitutions: Presentation of the recurrent A353V substitution ranges from classic DC to the severe HH variant. However, we do see that patients with HH have significantly shorter telomeres than those with a relatively mild presentation. In the new families described with TERC mutations, there is further evidence of disease anticipation associated with shorter telomeres in the younger generations. This study highlights the considerable genetic and phenotypic diversity of DC.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Autexier
POT of gold: modeling dyskeratosis congenita in the mouse
Genes & Dev.,
July 1, 2008;
22(13):
1731 - 1736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Vulliamy, R. Beswick, M. Kirwan, A. Marrone, M. Digweed, A. Walne, and I. Dokal
From the Cover: Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita
PNAS,
June 10, 2008;
105(23):
8073 - 8078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marrone, A. Walne, H. Tamary, Y. Masunari, M. Kirwan, R. Beswick, T. Vulliamy, and I. Dokal
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome
Blood,
December 15, 2007;
110(13):
4198 - 4205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Rumi, F. Passamonti, M. G. Della Porta, C. Elena, L. Arcaini, L. Vanelli, C. Del Curto, D. Pietra, E. Boveri, C. Pascutto, et al.
Familial Chronic Myeloproliferative Disorders: Clinical Phenotype and Evidence of Disease Anticipation
J. Clin. Oncol.,
December 10, 2007;
25(35):
5630 - 5635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Garcia, W. E. Wright, and J. W. Shay
Human diseases of telomerase dysfunction: insights into tissue aging
Nucleic Acids Res.,
December 3, 2007;
35(22):
7406 - 7416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Alter, G. M. Baerlocher, S. A. Savage, S. J. Chanock, B. B. Weksler, J. P. Willner, J. A. Peters, N. Giri, and P. M. Lansdorp
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita
Blood,
September 1, 2007;
110(5):
1439 - 1447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bessler, H.-Y. Du, B. Gu, and P. J. Mason
Dysfunctional telomeres and dyskeratosis congenita
Haematologica,
August 1, 2007;
92(8):
1009 - 1012.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marrone, P. Sokhal, A. Walne, R. Beswick, M. Kirwan, S. Killick, M. Williams, J. Marsh, T. Vulliamy, and I. Dokal
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations
Haematologica,
August 1, 2007;
92(8):
1013 - 1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Drummond, S. Balabanov, T. L. Holyoake, and T. H. Brummendorf
Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells
Stem Cells,
August 1, 2007;
25(8):
1853 - 1861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Walne, T. Vulliamy, A. Marrone, R. Beswick, M. Kirwan, Y. Masunari, F.-h. Al-Qurashi, M. Aljurf, and I. Dokal
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10
Hum. Mol. Genet.,
July 1, 2007;
16(13):
1619 - 1629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Center
Taking the "Idio" Out of Idiopathic Pulmonary Fibrosis: A Call to Arms
Am. J. Respir. Crit. Care Med.,
June 1, 2007;
175(11):
1101 - 1102.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-T. Xin, A. D. Beauchamp, R. T. Calado, J. W. Bradford, J. A. Regal, A. Shenoy, Y. Liang, P. M. Lansdorp, N. S. Young, and H. Ly
Functional characterization of natural telomerase mutations found in patients with hematologic disorders
Blood,
January 15, 2007;
109(2):
524 - 532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Alter
Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes
Hematology,
January 1, 2007;
2007(1):
29 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M.Y. Wong and K. Collins
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita
Genes & Dev.,
October 15, 2006;
20(20):
2848 - 2858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shimamura
Inherited Bone Marrow Failure Syndromes: Molecular Features
Hematology,
January 1, 2006;
2006(1):
63 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Marsh
Making Therapeutic Decisions in Adults with Aplastic Anemia
Hematology,
January 1, 2006;
2006(1):
78 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |